An Open-label, Single-armed Pilot Study to Evaluate the Efficacy of Icotinib in Previously Treated Non/Light-smoking Patients With Squamous Lung Cancer

Trial Profile

An Open-label, Single-armed Pilot Study to Evaluate the Efficacy of Icotinib in Previously Treated Non/Light-smoking Patients With Squamous Lung Cancer

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 03 Mar 2017

At a glance

  • Drugs Icotinib (Primary)
  • Indications Lung cancer; Squamous cell cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Mar 2015 Planned End Date changed from 1 Mar 2015 to 1 Mar 2016, as reported by ClinicalTrials.gov.
    • 04 Mar 2015 Planned primary completion date changed from 1 Jan 2015 to 1 Jan 2016, as reported by ClinicalTrials.gov.
    • 04 Mar 2015 Planned initiation date changed from 1 Mar 2014 to 1 Mar 2015, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top